Home Cart Sign in  
Chemical Structure| 1234423-95-0 Chemical Structure| 1234423-95-0

Structure of Tenapanor
CAS No.: 1234423-95-0

Chemical Structure| 1234423-95-0

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Tenapanor is an inhibitor of the sodium-proton (Na(+)/H(+)) exchanger NHE3, which plays a prominent role in sodium handling in the gastrointestinal tract and kidney, with IC50 values of 5 and 10 nM against human and rat NHE3, respectively.

Synonyms: RDX5791; AZD1722

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Tenapanor

CAS No. :1234423-95-0
Formula : C50H66Cl4N8O10S2
M.W : 1145.05
SMILES Code : O=S(C1=CC=CC([C@@H]2CN(C)CC3=C2C=C(Cl)C=C3Cl)=C1)(NCCOCCOCCNC(NCCCCNC(NCCOCCOCCNS(=O)(C4=CC=CC([C@@H]5CN(C)CC6=C5C=C(Cl)C=C6Cl)=C4)=O)=O)=O)=O
Synonyms :
RDX5791; AZD1722
MDL No. :MFCD28386333
InChI Key :DNHPDWGIXIMXSA-CXNSMIOJSA-N
Pubchem ID :71587953

Safety of Tenapanor

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01340053 Constipation Predominant Irrit... More >>able Bowel Syndrome Less << PHASE2 COMPLETED 2025-02-12 Ardelyx Investigational Site, ... More >>San Diego, California, 92108, United States|Ardelyx Investigational Site, Jupiter, Florida, 33458, United States|Ardelyx Investigational Site, Pinellas Park, Florida, 33782, United States|Ardelyx Investigational Site, Rockford, Illinois, 61107, United States|Ardelyx Investigational Site, Mission, Kansas, 66202, United States|Ardelyx Investigational Site, Monroe, Louisiana, 71201, United States|Ardelyx Investigational Site, Annapolis, Maryland, 21401, United States|Ardelyx Investigational Site, Chesterfield, Michigan, 48047, United States|Ardelyx Investigational Site, Saint Louis, Missouri, 63128, United States|Ardelyx Investigational Site, Brooklyn, New York, 11214, United States|Ardelyx Investigational Site, Greensboro, North Carolina, 27408, United States|Ardelyx Investigational Site, Oklahoma City, Oklahoma, 73104, United States|Ardelyx Investigational Site, Simpsonville, South Carolina, 29681, United States|Ardelyx Investigational Site, Bristol, Tennessee, 37620, United States|Ardelyx Investigational Site, Ogden, Utah, 84405, United States|Ardelyx Investigational Site, Lynchburg, Virginia, 24502, United States Less <<
NCT06810167 Cystic Fibrosis|Constipation PHASE3 NOT_YET_RECRUITING 2027-06-30 -
NCT04549597 Chronic Kidney Disease Requiri... More >>ng Chronic Dialysis|Hyperphosphatemia Less << PHASE4 COMPLETED 2021-12-01 South Florida Research Institu... More >>te, Lauderdale Lakes, Florida, 33313, United States Less <<
NCT05995899 IBS|IBS - Irritable Bowel Synd... More >>rome Less << PHASE4 RECRUITING 2025-11-26 Massachusetts General Hospital... More >>, Boston, Massachusetts, 02114, United States Less <<
NCT05905926 Irritable Bowel Syndrome With ... More >>Constipation (IBS-C) Less << PHASE3 ENROLLING_BY_INVITATION 2025-10-31 G & L Research, LLC, Foley, Al... More >>abama, 36535, United States|Advanced Research Center, Inc., Anaheim, California, 92805, United States|Prohealth Research Center, Doral, Florida, 33166, United States|I.H.S. Health, LLC, Kissimmee, Florida, 34741, United States|Valencia Medical and Research Center, Miami, Florida, 33165, United States|Florida Pharmaceutical Research and Associates, Inc., South Miami, Florida, 33143, United States|Boys Town National Research Hospital, Boys Town, Nebraska, 68010, United States|Advantage Clinical Trials, Bronx, New York, 10467, United States|SUNY Downstate Medical Center, Brooklyn, New York, 11203, United States|Atrium Health, Charlotte, North Carolina, 28203, United States|Frontier Clinical Research, LLC, Scottdale, Pennsylvania, 15683, United States|Frontier Clinical Research, LLC, Smithfield, Pennsylvania, 15478, United States|Prisma Health Children's Hospital, Greenville, South Carolina, 29615, United States|Texas Digestive Specialists, Harlingen, Texas, 78550, United States|AIM Trials, LLC, Plano, Texas, 75093, United States|Sun Research Institute, San Antonio, Texas, 78215, United States|Pioneer Research Solutions Inc, Sugar Land, Texas, 77479, United States|Frontier Clinical Research, Kingwood, West Virginia, 26537, United States Less <<
NCT02727751 Constipation Predominant Irrit... More >>able Bowel Syndrome Less << PHASE3 COMPLETED 2025-10-17 Ardelyx Clinical Site, Miami, ... More >>Florida, United States Less <<
NCT02063386 Healthy Volunteers PHASE1 COMPLETED 2025-05-14 Research Site, London, United ... More >>Kingdom Less <<
NCT06203444 Lactation PHASE1 COMPLETED 2024-05-30 DDSI, Oklahoma City, Oklahoma,... More >> 73112, United States|Fortrea Clinical Research Unit, Madison, Wisconsin, 53704, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

0.87mL

0.17mL

0.09mL

4.37mL

0.87mL

0.44mL

8.73mL

1.75mL

0.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories